Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$940M Sell
8,937,491
-804,957
-8% -$94.5M 0.06% 309
2025
Q4
$1.22B Buy
9,742,448
+1,177,283
+14% +$140M 0.07% 240
2025
Q3
$1.03B Sell
8,565,165
-532,467
-6% -$56.2M 0.06% 278
2025
Q2
$835M Buy
9,097,632
+336,056
+4% +$30.7M 0.05% 339
2025
Q1
$771M Buy
8,761,576
+943,473
+12% +$92.8M 0.06% 330
2024
Q4
$723M Buy
7,818,103
+3,821
+0% +$368K 0.05% 349
2024
Q3
$725M Buy
7,814,282
+649,848
+9% +$54.6M 0.05% 337
2024
Q2
$537M Buy
7,164,434
+1,110,636
+18% +$88.6M 0.04% 423
2024
Q1
$522M Sell
6,053,798
-6,370,168
-51% -$487M 0.04% 427
2023
Q4
$859M Buy
12,423,966
+5,739,450
+86% +$346M 0.04% 459
2023
Q3
$366M Buy
6,684,516
+1,271,685
+23% +$72.3M 0.04% 465
2023
Q2
$302M Buy
5,412,831
+927,554
+21% +$46.3M 0.03% 556
2023
Q1
$228M Buy
4,485,277
+2,205,844
+97% +$104M 0.02% 643
2022
Q4
$90.7M Buy
2,279,433
+151,014
+7% +$5.65M 0.01% 1084
2022
Q3
$68.6M Buy
2,128,419
+392,521
+23% +$14.3M 0.01% 1113
2022
Q2
$60.4M Buy
1,735,898
+865,117
+99% +$33.7M 0.01% 1243
2022
Q1
$34.9M Buy
870,781
+55,979
+7% +$2.66M ﹤0.01% 1561
2021
Q4
$43M Buy
814,802
+149,305
+22% +$7.36M 0.01% 1457
2021
Q3
$31.1M Buy
665,497
+40,691
+7% +$2.06M ﹤0.01% 1674
2021
Q2
$31.8M Sell
624,806
-6,066
-1% -$303K ﹤0.01% 1688
2021
Q1
$29.6M Buy
630,872
+236,856
+60% +$10.6M ﹤0.01% 1567
2020
Q4
$16.8M Buy
394,016
+7,673
+2% +$302K ﹤0.01% 1976
2020
Q3
$13.9M Buy
386,343
+74,329
+24% +$2.8M ﹤0.01% 1748
2020
Q2
$10.7M Buy
312,014
+71,417
+30% +$2.2M ﹤0.01% 1906
2020
Q1
$6.46M Sell
240,597
-466
-0.2% -$16K ﹤0.01% 2207
2019
Q4
$9.72M Buy
241,063
+175,562
+268% +$6.5M ﹤0.01% 2464
2019
Q3
$2.25M Buy
65,501
+4,581
+8% +$152K ﹤0.01% 3669
2019
Q2
$2M Sell
60,920
-441
-0.7% -$14.3K ﹤0.01% 3772
2019
Q1
$1.9M Sell
61,361
-112,299
-65% -$3.37M ﹤0.01% 3624
2018
Q4
$4.58M Buy
173,660
+897
+0.5% +$25.4K ﹤0.01% 3012
2018
Q3
$5.65M Buy
172,763
+91,721
+113% +$3.09M ﹤0.01% 3048
2018
Q2
$2.87M Buy
81,042
+6,630
+9% +$239K ﹤0.01% 3745
2018
Q1
$2.53M Sell
74,412
-52,978
-42% -$1.88M ﹤0.01% 3758
2017
Q4
$4.6M Buy
127,390
+4,426
+4% +$159K ﹤0.01% 3199
2017
Q3
$4.66M Sell
122,964
-317,656
-72% -$11.2M ﹤0.01% 3030
2017
Q2
$15.6M Buy
440,620
+278,462
+172% +$10M ﹤0.01% 1748
2017
Q1
$5.7M Sell
162,158
-15,791
-9% -$550K ﹤0.01% 2733
2016
Q4
$6.12M Sell
177,949
-633
-0.4% -$21.1K ﹤0.01% 2781
2016
Q3
$5.94M Sell
178,582
-55,041
-24% -$1.74M ﹤0.01% 2502
2016
Q2
$6.91M Sell
233,623
-25,450
-10% -$745K ﹤0.01% 2302
2016
Q1
$7.3M Sell
259,073
-784,450
-75% -$20.8M ﹤0.01% 2150
2015
Q4
$30.1M Buy
1,043,523
+53,893
+5% +$1.51M 0.01% 1119
2015
Q3
$26.3M Sell
989,630
-107,053
-10% -$3.1M 0.01% 1182
2015
Q2
$30.8M Sell
1,096,683
-38,375
-3% -$1.08M 0.01% 1166
2015
Q1
$29.7M Buy
1,135,058
+215,170
+23% +$5.6M 0.01% 1154
2014
Q4
$22.1M Buy
919,888
+860,411
+1,447% +$19.5M 0.01% 1409
2014
Q3
$1.36M Buy
59,477
+19,124
+47% +$462K ﹤0.01% 3771
2014
Q2
$1.04M Buy
40,353
+1,473
+4% +$41.7K ﹤0.01% 4020
2014
Q1
$1.1M Buy
38,880
+2,490
+7% +$68.2K ﹤0.01% 3911
2013
Q4
$930K Sell
36,390
-2,096
-5% -$51.9K ﹤0.01% 3985
2013
Q3
$930K Sell
38,486
-32,085
-45% -$707K ﹤0.01% 3857
2013
Q2
$1.43M Buy
+70,571
New +$1.49M ﹤0.01% 3408

Other funds holding CRH

Morgan Stanley's CRH Position: Q1 2026 in Review

Morgan Stanley reduced its CRH (CRH) stake by 8.3% in Q1 2026, selling an estimated $94.5M and leaving 8,937,491 shares worth $940M. The position accounts for 0.06% of the portfolio, ranked #309.

Morgan Stanley first reported a position in CRH in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.22B in Q4 2025. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Morgan Stanley held 8,937,491 shares of CRH worth $940M as of Q1 2026.
  • Morgan Stanley sold 804,957 CRH shares in Q1 2026, an estimated $94.5M.
  • CRH made up 0.06% of Morgan Stanley's portfolio in Q1 2026, its #309 holding.
  • Morgan Stanley first reported a position in CRH in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's CRH position peaked at $1.22B in Q4 2025.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.